Skip to main content

Tenting of the Mitral Valve

 


Tenting of the Mitral Valve: Understanding an Important Echocardiographic Marker


Introduction


Mitral valve tenting is an important echocardiographic finding frequently encountered in patients with functional or secondary mitral regurgitation (MR). It reflects distortion of the normal mitral valve geometry due to left ventricular remodeling and papillary muscle displacement, resulting in incomplete leaflet coaptation.


Recognition and quantification of mitral valve tenting provide valuable information regarding the severity of ventricular remodeling, the mechanism of mitral regurgitation, and potential treatment strategies.


---


What is Mitral Valve Tenting?


Mitral valve tenting refers to the apical displacement of the mitral leaflets during systole below the plane of the mitral annulus, creating a characteristic "tent-like" appearance on echocardiography.


Normally, mitral leaflets coapt at or slightly above the annular plane. When ventricular dilation or remodeling pulls the papillary muscles downward and outward, the leaflets become tethered and fail to close properly, leading to tenting.


---


Pathophysiology


Mitral valve closure depends on a delicate balance between:


- Closing forces generated by left ventricular systolic contraction.

- Tethering forces exerted by chordae tendineae and papillary muscles.


Conditions causing left ventricular remodeling increase tethering forces and reduce leaflet mobility.


The sequence typically involves:


1. Left ventricular dilation or regional wall motion abnormality.

2. Displacement of papillary muscles posteriorly, laterally, or apically.

3. Increased leaflet tethering.

4. Apical displacement of the coaptation point.

5. Development of mitral leaflet tenting.

6. Functional mitral regurgitation.


---


Causes of Mitral Valve Tenting


Ischemic Heart Disease


- Inferior myocardial infarction.

- Posterior myocardial infarction.

- Ischemic cardiomyopathy.


Regional remodeling often causes asymmetric tenting.


Dilated Cardiomyopathy


- Idiopathic dilated cardiomyopathy.

- Non-ischemic cardiomyopathy.

- Advanced heart failure.


This typically produces symmetric leaflet tethering.


Left Ventricular Remodeling


- Chronic hypertension.

- Post-myocarditis cardiomyopathy.

- Valvular cardiomyopathies.


Cardiac Resynchronization Therapy Candidates


Patients with ventricular dyssynchrony may develop significant tenting that can improve after CRT.


---


Echocardiographic Assessment


Mitral valve tenting is usually evaluated in:


- Parasternal long-axis view.

- Apical four-chamber view.

- Apical two-chamber view.

- Three-dimensional echocardiography.


Measurements are performed during mid-systole when leaflet tethering is maximal.


---


Important Tenting Parameters


1. Tenting Height


Distance from the mitral annular plane to the leaflet coaptation point.


Normal value:


- Less than 10 mm


Significant tenting:


- Greater than 10 mm


Severe tethering:


- Greater than 11–12 mm


---


2. Tenting Area


Area enclosed between the mitral annular plane and the mitral leaflets during systole.


Normal value:


- Less than 1 cm²


Abnormal:


- Greater than 2 cm²


Severe tenting:


- Greater than 2.5 cm²


---


3. Tenting Volume


Three-dimensional volume enclosed by the annular plane and leaflets.


Normal value:


- Less than 2.3 mL


Higher values indicate advanced ventricular remodeling and more severe tethering.


---


4. Coaptation Depth


Distance from the annular plane to leaflet coaptation.


Normal:


- Less than 10 mm


Abnormal:


- Greater than 10 mm


---


5. Posterior Leaflet Angle


Angle between the posterior mitral leaflet and annular plane.


Significant tethering:


- Greater than 45°


A posterior leaflet angle exceeding 45° predicts recurrent MR after repair.


---


6. Anterior Leaflet Angle


Angle between anterior leaflet and annular plane.


Abnormal:


- Greater than 25–30°


---


Symmetric Versus Asymmetric Tenting


Symmetric Tenting


Characteristics:


- Central regurgitant jet.

- Global left ventricular dilation.

- Both leaflets restricted.


Commonly seen in:


- Dilated cardiomyopathy.


Asymmetric Tenting


Characteristics:


- Eccentric regurgitant jet.

- Predominant posterior leaflet restriction.

- Regional wall motion abnormalities.


Commonly seen in:


- Ischemic mitral regurgitation.


---


Clinical Significance


Mitral valve tenting is more than an echocardiographic observation; it has important clinical implications.


Indicates Severity of Ventricular Remodeling


Increasing tenting reflects progressive ventricular dysfunction.


Predicts Functional Mitral Regurgitation


Greater tethering correlates with more severe MR.


Predicts Outcomes


Larger tenting area and height are associated with:


- Increased heart failure hospitalization.

- Reduced survival.

- Worse ventricular function.


Surgical Planning


Patients with severe tenting may have:


- Higher rates of recurrent MR after annuloplasty alone.

- Need for subvalvular repair techniques or valve replacement.


Transcatheter Interventions


Assessment of tenting is important when evaluating suitability for transcatheter edge-to-edge repair procedures.


---


Role of Three-Dimensional Echocardiography


Three-dimensional echocardiography offers:


- Accurate measurement of tenting volume.

- Better visualization of leaflet tethering.

- Detailed assessment of annular geometry.

- Improved procedural planning.


It is increasingly becoming the preferred modality for comprehensive mitral valve analysis.


---


Can Mitral Valve Tenting Improve?


Yes. Tenting may improve if ventricular remodeling is reversed through:


- Guideline-directed medical therapy for heart failure.

- Cardiac resynchronization therapy.

- Coronary revascularization in ischemic disease.

- Left ventricular assist devices in advanced cases.


Reduction in ventricular size often decreases tethering and improves mitral regurgitation.


---


Key Take-Home Messages


- Mitral valve tenting is a marker of leaflet tethering due to ventricular remodeling.

- It is most commonly associated with functional or secondary mitral regurgitation.

- Tenting height, area, volume, and leaflet angles are key echocardiographic measurements.

- Greater tenting predicts more severe mitral regurgitation and poorer outcomes.

- Quantification of tenting plays an important role in therapeutic decision-making and procedural planning.


---


Conclusion


Mitral valve tenting represents the interaction between the mitral valve and the left ventricular apparatus rather than a primary leaflet abnormality. Careful echocardiographic assessment of tenting parameters provides valuable insights into disease severity, prognosis, and management options in patients with functional mitral regurgitation.


As imaging technologies continue to evolve, particularly with three-dimensional echocardiography, evaluation of mitral valve tenting has become an indispensable component of modern valvular heart disease assessment.

Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...